References
- Charles T, Penninga L, Reurings JC, et al. Intussusception in children: a clinical review. Acta Chir Belg. 2015;115(5):327–333.
- Huppertz HI, Soriano-Gabarró M, Grimprel E, et al. Intussusception among young children in Europe. Pediatr Infect Dis J. 2006;25(1 Suppl):S22–29.
- Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344(8):564–572.
- Rha B, Tate JE, Weintraub E, et al. Intussusception following rotavirus vaccination: an updated review of the available evidence. Expert Rev Vaccines. 2014;13(11):1339–1348.
- WHO-WER9628 [Internet]. World health organization: strategic advisory group of experts on immunization; [cited 2022 Sep 17]. Available from: https://www.who.int/publications/i/item/WHO-WER9628.
- Zhang T, Cui L, Geng X, et al. Epidemiology study of pediatric primary intussusception aged ≤24 months in pre-rotavirus vaccine era of Jinan, China. Vaccine. 2019;37(11):1436–1442.
- Zhang H, Lai X, Mak J, et al. Coverage and equity of childhood vaccines in China. JAMA Network Open. 2022;5(12):e2246005.
- Dodd C, Andrews N, Petousis-Harris H, et al. Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions. BMJ Glob Health. 2021;6(Suppl 2):e003540.
- Klonoff DC. The new FDA real-world evidence program to support development of drugs and biologics. J Diabetes Sci Technol. 2020;14(2):345–349.
- Fda.gov [Internet]. Food and drug administration: framework for FDA’s real world evidence program; [cited 2022 Sep 18]. Available from: https://www.fda.gov/media/120060/download.
- Fda.gov [Internet]. Food and drug administration: real-world data: assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products; [cited 2022 Sep 18]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/real-world-data-assessing-electronic-health-records-and-medical-claims-data-support-regulatory.
- Bines JE, Liem NT, Justice F, et al. Validation of clinical case definition of acute intussusception in infants in Viet Nam and Australia. Bull World Health Organ. 2006;84(7):569–575.
- Ducharme R, Benchimol EI, Deeks SL, et al., Validation of diagnostic codes for intussusception and quantification of childhood intussusception incidence in Ontario, Canada: a population-based study. J Pediatr. 2013. 163(4): 1073–1079.e3.
- Schollin A, Svensson JF, Olén O, et al. Clinical presentation of intussusception in Swedish children under 3 years of age and the validity of diagnostic coding. Pediatr Surg Int. 2019;35(3):373–381.
- Sun Y, Zhang L, Li N, et al., No association between enterovirus 71 (EV71) vaccination and risk of febrile seizures: a population-based near real-time surveillance study. Expert Rev Vaccines. 2022. 21(1): 125–134.
- Liu Z, Zhang L, Yang Y, et al. Active surveillance of adverse events following human papillomavirus vaccination: feasibility pilot study based on the regional health care information platform in the city of Ningbo, China. J Med Internet Res. 2020;22(6):e17446.
- Yu L, Li Y, Zhang QY. Analysis of the second type of vaccination for children aged 1 to 6 in the central urban area of Yinzhou District in 2017. Chin Rural Health Serv Admin. 2018;38(8):1031–1033.
- Xu L, Li N, Zhang L, et al. Febrile seizures and measles-containing vaccines in China: a self-controlled case series study. Vaccines (Basel). 2021;9(10):1073.
- Bines JE, Kohl KS, Forster J, et al., Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004. 22(5–6): 569–574.
- Fagerland MW, Lydersen S, Laake P. Recommended tests and confidence intervals for paired binomial proportions. Stat Med. 2014;33(16):2850–2875.
- Mcilhone KA, Best EJ, Petousis-Harris H, et al. Impact of rotavirus vaccine on paediatric rotavirus hospitalisation and intussusception in New Zealand: a retrospective cohort study. Vaccine. 2020;38(7):1730–1739.
- Huang WT, Juan YC, Liu CH, et al. Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants. Vaccine. 2020;38(40):6299–6303.
- Yih WK, Lieu TA, Kulldorff M, et al. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med. 2014;370(6):503–512.
- Shui IM, Baggs J, Patel M, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. Jama. 2012;307(6):598–604.
- Pérez-Vilar S, Díez-Domingo J, Puig-Barberà J, et al. Intussusception following rotavirus vaccination in the Valencia region, Spain. Hum Vaccin Immunother. 2015;11(7):1848–1852.
- Weihmiller SN, Buonomo C, Bachur R. Risk stratification of children being evaluated for intussusception. Pediatrics. 2011;127(2):e296–e303.